Business Standard

Over 340 'irrational' drugs to go off shelves soon; many more under scanner

To hit Rs 20-bn market; 944 more fixed-dosage combination drugs under scanner

Approval for generics drug up but US business shrinks for home firms
Premium

Sohini DasAneesh PhadnisVeena Mani Mumbai/New Delhi
The Centre is one step closer to banning 343 “irrational” fixed-dose combination (FDC) drugs that were potentially harmful to consumers. The market size of the banned drugs is estimated to be around Rs 20-22 billion and will impact the country’s top drugmakers.

Patient advocacy groups say more FDCs, worth Rs 200-250 billion, are under scanner. An FDC drug is one that contains two or more active ingredients in a fixed-dosage ratio. 

In March 2016, the ministry of health and family welfare had implemented a ban on 349 FDCs based on recommendations of the Chandrakant Kokate committee that found these drug

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in